Follow
Giulia Massaro
Giulia Massaro
MD, Università di Pisa
No verified email
Title
Cited by
Cited by
Year
Safety and tolerability of COVID-19 vaccines in patients with cancer: a single center retrospective analysis
A Nuzzo, S Manacorda, E Sammarco, A Sbrana, S Bazzurri, F Paolieri, ...
Vaccines 10 (6), 892, 2022
12022
The treatment of Advanced Melanoma: Current approaches and new challenges
A Boutros, E Croce, M Ferrari, R Gili, G Massaro, R Marconcini, L Arecco, ...
Critical Reviews in Oncology/Hematology, 104276, 2024
2024
1199P MAVERIC: Phase II randomized study of everolimus as maintenance therapy for metastatic neuroendocrine neoplasms (mNEN) with pulmonary or gastroenteropancreatic (GEP …
L Antonuzzo, S Pillozzi, R Marconcini, F Spada, F Gelsomino, V Amoroso, ...
Annals of Oncology 34, S707-S708, 2023
2023
FIRST-LINE COMBINATION THERAPIES FOR ADVANCED RENAL CELL CARCINOMA (ARCC): AN ITALIAN SINGLE-CENTRE REAL-WORLD CLINICAL EXPERIENCE
C Mercinelli, G Massaro, A Bonato, A Nuzzo, S Manacorda, E Sammarco, ...
ANTICANCER RESEARCH 42 (10), 5144-5145, 2022
2022
Comparison between first line target therapy and immunotherapy in different prognostic categories of BRAF mutant metastatic melanoma patients: an Italian Melanoma Intergroup study
R Marconcini, P Fava, A Nuzzo, S Manacorda, M Ferrari, F De Rosa, ...
Frontiers in Oncology, 3459, 2022
2022
Safety and tolerability of COVID-19 vaccines in patients with cancer: a single center retrospective analysis (preprint)
A Nuzzo, S Manacorda, E Sammarco, A Sbrana, S Bazzurri, F Paolieri, ...
2022
750P Safety and efficacy of platinum desensitization treatment in patients with ovarian cancer and platinum hypersensitivity
A Nuzzo, S Manacorda, F Paolieri, A Sbrana, S Bazzurri, E Sammarco, ...
Annals of Oncology 32, S743-S744, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7